PANews reported on February 22 that, according to analyst defioasis.eth, Polymarket Builders' trading volume reached $125 million in the past week, marking the PANews reported on February 22 that, according to analyst defioasis.eth, Polymarket Builders' trading volume reached $125 million in the past week, marking the

Polymarket Builders' weekly trading volume has exceeded $100 million for three consecutive weeks.

2026/02/22 09:49
1 min read

PANews reported on February 22 that, according to analyst defioasis.eth, Polymarket Builders' trading volume reached $125 million in the past week, marking the third consecutive week that it has surpassed the $100 million mark, with the number of weekly trading addresses exceeding 10,000 for two consecutive weeks.

In terms of cumulative trading volume, Betmoar leads other platforms with a 50.6% market share exceeding $550 million. Other platforms with cumulative trading volumes exceeding $50 million include PolyTraderPro, PolyCop, Stand, Polymtrade, and Preddy Trade.

In terms of trading addresses, Polymtrade became the first Builder to surpass 10,000 traders and is using the fees collected for token buybacks. Other Builders with more than 1,000 trading addresses include Polygun, Polycule, PolyCop, Based, Rainbow, Chance, betmoar, and PolyBot.

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.000829
$0.000829$0.000829
+21.14%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.